Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Koninklijke Philips N.V.    PHIA   NL0000009538

KONINKLIJKE PHILIPS N.V.

(PHIA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Koninklijke Philips N : U.S. scraps Philips ventilator order in 2020 earnings blow

08/31/2020 | 06:52am EST
FILE PHOTO: Philips headquarters is pictured in Barueri, on the outskirts of Sao Paulo

Philips said the U.S. Department of Health had cancelled most of an order for 43,000 ventilators, leading the Dutch medical equipment maker to cut its 2020 earnings outlook.

The termination follows a July report by the U.S. Congress House Subcommittee on Economic and Consumer Policy that found the White House had overpaid Philips by at least $500 million. Philips denied any profiteering on ventilators.

Philips was one of several firms contracted by the U.S. to supply 187,000 ventilators to the strategic national stockpile to treat patients affected by COVID-19.

It expanded capacity in Pennsylvania and California to meet sudden demand but said in a statement on Monday that it will now deliver just 12,300 hospital ventilators by the end of the year to the U.S. Department of Health and Human services.

A spokesman said he expected Philips will find other buyers for the 30,700 excess ventilators.

Shares in Philips, which are down 4.3% in the year to date, dipped 0.6% to 40.84 euros.

"We continue to expect to return to growth and improved profitability in the second half of the year, starting in the third quarter," Philips chief executive Frans van Houten said.

Philips had said in July that the surge in orders for medical equipment would enable it to achieve an "adjusted EBITA (earnings before interest, taxes, and amortisation) margin improvement" this year.

But it said on Monday it expects "to deliver modest comparable sales growth with an adjusted EBITA margin of around the level of last year".

Philips' core earnings fell almost a quarter in April-June to 418 million euros ($497.25 million) as sales dropped 6% to 4.4 billion euros.

ING, which rates Philips shares "hold", said in a note the news was a slight negative as analysts were already expecting flat margins this year.

(Reporting by Anthony Deutsch and Toby Sterling; Editing by Louise Heavens and Alexander Smith)


© Reuters 2020
All news about KONINKLIJKE PHILIPS N.V.
01/22KONINKLIJKE PHILIPS N : Frans van Houten on COVID-19 response, recovery and the ..
PU
01/20KONINKLIJKE PHILIPS N.V. : annual earnings release
01/20PHILIPS NV : Berenberg reaffirms its Buy rating
MD
01/20KONINKLIJKE PHILIPS N : Philips to expand its leadership in patient care managem..
AQ
01/20KONINKLIJKE PHILIPS N : Philips Strikes $635 Million Acquisition Deal for US-bas..
MT
01/19KONINKLIJKE PHILIPS N : The fight of our lives to ensure health for all
PU
01/19KONINKLIJKE PHILIPS N : Philips to Acquire Capsule Technologies for $635 Million..
MT
01/19PHILIPS NV : JP Morgan remains Neutral
MD
01/19KONINKLIJKE PHILIPS N : Philips Acquires Data Company Capsule Technologies for $..
MT
01/19KONINKLIJKE PHILIPS N : Philips to Buy Capsule Technologies for $635 Million
DJ
More news
Financials
Sales 2020 19 583 M 23 831 M 23 831 M
Net income 2020 1 250 M 1 521 M 1 521 M
Net Debt 2020 3 219 M 3 917 M 3 917 M
P/E ratio 2020 33,2x
Yield 2020 1,91%
Capitalization 41 504 M 50 522 M 50 506 M
EV / Sales 2020 2,28x
EV / Sales 2021 2,26x
Nbr of Employees 80 718
Free-Float 99,7%
Chart KONINKLIJKE PHILIPS N.V.
Duration : Period :
Koninklijke Philips N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KONINKLIJKE PHILIPS N.V.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 49,64 €
Last Close Price 45,64 €
Spread / Highest target 38,1%
Spread / Average Target 8,77%
Spread / Lowest Target -16,7%
EPS Revisions
Managers and Directors
NameTitle
Frans van Houten Chief Executive Officer
Jeroen van der Veer Chairman-Supervisory Board
Sophie Bechu Chief Operating Officer & Executive Vice President
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Jan Kimpen Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
KONINKLIJKE PHILIPS N.V.4.24%50 522
THERMO FISHER SCIENTIFIC10.00%203 954
DANAHER CORPORATION7.16%169 098
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.12.25%89 689
INTUITIVE SURGICAL, INC.-9.05%87 471
ILLUMINA, INC.9.80%59 313